rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Obesity, Fatty Liver and Liver Cancer
  name:
    name part: Yu, Jun.
    role:
      role term: editor.
    role:
      role term: edt
    role:
      role term: http://id.loc.gov/vocabulary/relators/edt
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  origin info:
    place:
      place term: si
    date issued: 2018
    edition: 1st ed. 2018.
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: electronic
    form: electronic resource
    reformatting quality: access
    form: remote
    extent: XII, 157 p. 24 illus., 23 illus. in color. online resource.
  abstract: This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together under one umbrella, from epidemiology and etiology, molecular pathogenesis, cellular biology, epigenetics, immunology, microbiology, animal models to therapeutic approaches and treatments. All the book contributors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery.
  table of contents: Chapter 1. Introduction -- Chapter 2. Epidemiology and etiology of NAFLD and associated HCC -- Chapter 3. Pathogenesis of NASH: How metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease -- Chapter 4. Chemokines and Chemokine Receptors in the Development of NAFLD -- Chapter 5. NAFLD related-HCC: the relationship with metabolic disorders -- Chapter 6. Hepatocellular carcinoma in obesity: Finding a needle in the haystack? -- Chapter 7. Dysregulated epigenetic modifications in the pathogenesis of NAFLD-HCC -- Chapter 8. The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease -- Chapter 9. Microbiota, obesity and NAFLD -- Chapter 10. Autophagy, NAFLD and NAFLD-related HCC -- Chapter 11. Animal models of non-alcoholic fatty liver diseases and its associated liver cancer -- Chapter 12. Current prevention and treatment options for NAFLD.
  note: edited by Jun Yu.
  subject:
    topic: Molecular biology
  subject:
    topic: Cancer research
  subject:
    topic: Hepatology
  subject:
    topic: Molecular Medicine
  subject:
    topic: Cancer Research
  subject:
    topic: Hepatology
  classification: QH506
  classification: 611.01816
  related item:
    title info:
      title: Springer eBooks
  related item:
    title info:
      title: Advances in Experimental Medicine and Biology, 1061
  identifier: 9789811086847
  identifier: https://doi.org/10.1007/978-981-10-8684-7
  record info:
    record creation date: 180628
    record change date: 20191021214718.0
    record identifier: 978-981-10-8684-7